NCT07233252
- Conditions
- Kidney-sparing, Nab-paclitaxel, PD-1 Inhibitor, +2 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
Clinical trial condition
Kidney-sparing
Explore clinical trials studying Kidney-sparing. Study availability and eligibility vary by location and protocol.
2 public trials
2 recruiting studies
Kidney-sparing trial results
Recruiting
Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer
NCT07125547
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney-sparing, +14 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China